5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice

Behavioural Brain Research

Volumn 187, Issue 1, 2008, Pages 72-79

  Nunes de Souza, Vanessa ^a   Nunes de Souza, Ricardo Luiz ^b   Rodgers, Robert John ^c   Canto de Souza, Azair ^a  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

5 HT2 receptors; Anxiety; Elevated plus maze; Ketanserin; mCPP; Mice; PAG

Indexed keywords

KETANSERIN; SEROTONIN 2 RECEPTOR; SEROTONIN 2A ANTAGONIST; SEROTONIN 2B RECEPTOR; SEROTONIN 2C ANTAGONIST; (3 CHLOROPHENYL)PIPERAZINE; 1-(3-CHLOROPHENYL)PIPERAZINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EXPOSURE; EXPERIMENTAL STUDY; FOREBRAIN; LOCOMOTION; MALE; MEASUREMENT; MENTAL TEST; MESENCEPHALON; MOUSE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; POPULATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VIDEOTAPE; ANIMAL; ANIMAL BEHAVIOR; DOSE RESPONSE; DRUG EFFECT; MICROINJECTION; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; KETANSERIN; MALE; MESENCEPHALON; MICE; MICROINJECTIONS; PERIAQUEDUCTAL GRAY; PIPERAZINES; PYRIDINES; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 36749049746     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.08.030     Document Type: Article

References (57)

1. Aguiar D.C., Moreira F.A., and Guimarães F.S. Flight reactions induced by injection of glutamate N-methyl-d-aspartate receptor agonist into the rat dorsolateral periaqueductal gray are not dependent on endogenous nitric oxide. Pharmacol Biochem Behav 83 (2006) 296-301
2. 2C agonists into ventral but not dorsal hippocampus. Behav Pharmacol 15 (2004) 37-43
3. 1A receptor antagonist WAY 100635. Int J Neuropsychopharmacol 4 (2001) 399-408
4. Bandler R., Depaulis A., and Vergnes M. Identification of midbrain neurones mediating defensive behaviour in the rat by microinjections of excitatory amino acids. Behav Brain Res 15 2 (1985) 107-119
5. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
6. Benjamin J., Geraci M., McGann U., Greenberg B.D., and Murphy D.L. Attenuated response to m-CPP and to pentagastrin after repeated m-CPP in panic disorder. Psychopharmacology 143 (1999) 215-216
7. Bilkei-Gorzo A., Gyertyan I., and Levay G. mCPP-induced anxiety in the light-dark box in rats-a new method for screening anxiolytic activity. Psychopharmacology 139 (1998) 291-298
8. Bjorvatn B., Fornal C.A., Martín F.J., Metzler C.W., and Jacobs B.L. Venlafaxine and its interaction with WAY 100635: effects on serotonergic units activity and behavior in cats. Eur J Pharmacol 404 (2000) 121-132
9. Blanchard R.J., and Blanchard D.C. Ethoexperimental approaches to the biology of emotion. Annu Rev Psychol 39 (1988) 43-68
10. Blier P., and de Montigny C. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 21 2S (1999) 91-98
11. Canto-de-Souza A., Nunes-de-Souza R.L., and Rodgers R.J. Anxiolytic-like effect of WAY-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience. Brain Res 928 (2002) 50-59
12. Carvalho-Netto E.F., Markham C., Blanchard C.D., Nunes-de-Souza R.L., and Blanchard R.J. Physical environment modulates the behavioral responses induced by chemical stimulation of dorsal periaqueductal gray in mice. Pharmacol Biochem Behav 85 (2006) 140-147
13. Castilho V.M., de Macedo C.E., and Brandão M.L. Role of benzodiazepine and serotonergic mechanisms in conditioned freezing and antinociception using electrical stimulation of the dorsal periaqueductal gray as unconditioned stimulus in rats. Psychopharmacology 165 (2002) 77-85
14. Charney D.S., Woods S.W., Goodman W.K., and Heninger G.R. Serotonin function in anxiety. II. Effects of the serotonin agonist mCPP on panic disorder patients and healthy subjects. Psychopharmacology (Berl) 92 (1987) 14-21
15. 2 receptors and anxiety. Behav Pharmacol 6 (1995) 35
16. Cornélio A.M., and Nunes-de-Souza R.L. Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze. Behav Brain Res 178 (2007) 82-89
17. Cruz A.P.M., Frei F., and Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 49 (1994) 171-176
18. Cruz A.P.M., Pinheiro G., Alves S.H., Ferreira G., Mendes M., Faria L., et al. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze. Psychopharmacology 182 (2005) 345-354
19. Dave K.D., Harvey J.A., and Aloyo V.J. A novel behavioral model that discriminates between 5-HT2A and 5-HT2C receptor activation. Pharmacol Biochem Behav 72 1/2 (2002) 371-378
20. Deakin J.F.W., and Graeff F.G. 5-HT and mechanisms or defence. J Psychopharmacol 5 (1991) 305-315
21. Di Scala G., Schmitt P., and Karli P. Flight induced by infusion of bicuculline methiodide into periventricular structures. Brain Res 309 2 (1984) 199-208
22. 2B receptor protein in the central nervous system. Neuroscience 76 (1997) 323-329
23. File S.E. Behavioural detection of anxiolytic action. In: Elliott J.M., Heal D.J., and Marsden C.A. (Eds). Experimental approaches to anxiety and depression (1992), John Wiley and Sons, Chichester 25-44
24. Fornal C.A., Metzler C.W., Gallegos R.A., Veasey S.C., McCreary A.C., and Jacobs B.L. WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135. J Pharmacol Exp Ther 27 (1996) 752-762
25. Graeff F.G., Guimarães F.S., Andrade T.G.C.S., and Deakin J.F.W. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 54 1 (1996) 129-141
26. Graeff F.G., Viana M.B., and Mora P.O. Dual role of 5-HT in defense and anxiety. Neurosci Biobehav Rev 21 6 (1997) 791-799
27. Graeff F.G. Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 3 (2004) 239-259
28. Griebel G., Misslin R., Pawlowski M., and Vogel E. m-Chlorophenylpiperazine enhances neophobic and anxious behaviours in mice. NeuroReport 2 (1991) 627-629
29. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65 (1995) 319-395
30. 1A receptors. Neurosci Lett 304 (2001) 129-132
31. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., et al. VII International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). J Pharmacol Exp Ther 46 (1994) 157-203
32. 2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus-maze. Psychopharmacology 164 (2002) 214-220
33. 1C receptor antagonists. Eur J Pharmacol 164 (1989) 445-454
34. Klein E., Zohar J., Geraci M.F., Murphy D.L., and Udhe T.W. Anxiogenic effects of m-CPP in patients with panic disorder: comparison of caffeine's anxiogenic effects. Biol Psychiatry 30 (1991) 973-984
35. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92 (1987) 180-185
36. Menard J., and Treit D. Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci Biobehav Rev 23 (1999) 591-613
37. Miguel T.T., and Nunes-de-Souza R.L. Defensive-like behaviors and antinociception induced by NMDA injection into the periaqueductal gray of mice depend on nitric oxide synthesis. Brain Res 1076 (2006) 42-48
38. Millan M.J. The neurobiology and control of anxious states. Progr Neurobiol 70 (2003) 83-244
39. 2C receptor blockade. Psychopharmacology 177 (2005) 1-12
40. Mueller E.A., Murphy D.L., and Sunderland T. Neuroendocrine effects of m-chlorophenylpiperazine, a serotonin agonist, in humans. J Clin Endocrinol Metab 61 (1985) 1179-1184
41. Mundey M.K., Fletcher A., and Marsden C.A. Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing. Br J Pharmacol 117 (1996) 750-756
42. 2 ligands on three mouse models of anxiety. Behav Brain Res 140 (2003) 203-214
43. Nogueira R.L., and Graeff F.G. 5-HT mediation of the antiaversive effect of isamoltane injected into the dorsal periaqueductal grey. Behav Pharmacol 2 1 (1991) 73-77
44. Nunes-de-Souza R.L., Canto-de-Souza A., Da-Costa M., Fornari R.V., Pelá I.R., and Graeff F.G. Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam. Psychopharmacology 150 (2000) 300-310
45. Nunes-de-Souza R.L., Canto-de-Souza A., and Rodgers R.J. Effects of intra-hippocampal infusion of WAY 100635 on plus-maze behavior in mice. Influence of site of injection and prior test experience. Brain Res 9 (2002) 87-96
46. 2 receptor mechanisms of the dorsal periaqueductal gray in the conditioned and unconditioned fear in rats. Psychopharmacology 191 (2007) 253-262
47. Paxinos G., and Franklin K.B.J. The mouse brain in stereotaxic coordinates (2001), Elsevier Science, California
48. Rodgers R.J., Cole J.C., Cobain M.R., Daly P., Doran P.J., Eells J.R., et al. Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS12066B, TFMPP and mCPP. Behav Pharmacol 3 (1992) 621-634
49. Rodgers R.J., and Johnson N.J.T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52 (1995) 297-303
50. Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., and Dourish C.T. Behavioural and pharmacological characterisation of the elevated 'zero-maze' as an animal model of anxiety. Psychopharmacology 116 (1994) 56-64
51. Soares V.P., and Zangrossi Jr. H. Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-maze. Brain Res Bull 64 (2004) 181-188
52. Southwick S.M., Krystal J.H., Bremner J.D., Morgan III C.A., Nicolaou A.L., Nagy L.M., et al. Noradenergic and serotonergic function in posttraumatic stress disorder. Arch Gen Psychiatry 54 (1997) 749-758
53. Treit D., Menard J., and Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44 (1993) 463-469
54. Vertes R.P., Fortin W.J., and Crane A.M. Projections of the median raphe nucleus in the rat. J Comp Neurol 407 (1999) 555-582
55. Whitton P., and Curzon G. Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus. Psychopharmacology 100 (1990) 138-140
56. Zangrossi H., and Graeff F.G. Behavioral effects of intra-amygdala injections of GABA and 5-HT acting drugs in the elevated plus-maze. Braz J Med Biol Res 27 (1994) 2453-2456
57. Zangrossi H., Viana M.B., Zanoveli J., Bueno C., Nogueira R.L., and Graeff F.G. Serotonergic regulation of inhibitory avoidance and one-way escape in the rat elevated T-maze. Neurosci Biobehav Rev 25 (2001) 637-645